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ABSTRACT
Immunoglobulin molecules specifically recognize
particular areas on the surface of proteins. These
areas are commonly dubbed B-cell epitopes. The
identification of epitopes in proteins is important
both for the design of experiments and vaccines.
Additionally, the interactions between epitopes and
antibodies have often served as a model for protein–
protein interactions. One of the main obstacles in
creating a database of antigen–antibody interactions
is the difficulty in distinguishing between antigenic
and non-antigenic interactions. Antigenic interac-
tions involve specific recognition sites on the anti-
body’s surface, while non-antigenic interactions are
between a protein and any other site on the antibody.
To solve this problem, we performed a comparat-
ive analysis of all protein–antibody complexes for
which structures have been experimentally determ-
ined. Additionally, we developed a semi-automated
tool that identified the antigenic interactions within
the known antigen–antibody complex structures.
We compiled those interactions into Epitome, a
database of structure-inferred antigenic residues in
proteins. Epitome consists of all known antigen/
antibody complex structures, a detailed description
of the residues that are involved in the interac-
tions, and their sequence/structure environments.
Interactions can be visualized using an interface
to Jmol. The database is available at http://www.
rostlab.org/services/epitome/.
BACKGROUND
Protein–antigen structures
Antigen–antibody complexes have long been used as a model
for understanding the general phenomenon of molecular
recognition (1–5). The number of experimental high-
resolution 3D structures of antibody–antigen complexes in
the PDB (6) has signiﬁcantly increased over the last years.
Several groups have used these data to analyze and charac-
terize antigenic interactions, i.e. interactions between the pro-
tein (the antigen) and the Complementarity Determining
Regions (CDRs) of the antibody (7,8). An important ﬁrst
step in studying antigenic interactions is the characterization
of CDRs. MacCallum etal.(8) observed that the hypervariable
loops of CDRs adopt only a limited number of backbone
conformations that are determined by a few key residues.
Two recent studies have suggested that the amino acid com-
position and the length of CDRs determine the type of antigen
that can be bound (9,10). Several studies have attempted to
differentiate the residues on the antigen surface that are
involved in the antigenic interaction from all others
(5,7,11). The results of these studies were rather inconsistent.
Differences in the data sets chosen (some of which were very
small) and in the methodologies may explain some of those
inconsistencies. Most importantly, however, the deﬁnitions of
the CDRs often differed greatly, i.e. if two studies investigate
the same PDB complex and use the same methodology, they
might disagree on which of the interactions are antigenic (7).
An important ramiﬁcation of this problem was unveiled by
Blythe and Flower (12), who showed that most existing B-cell
epitope prediction methods do not work adequately. One
explanation for this observation could be that most methods
rely on inaccurate identiﬁcations of epitopes.
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Antibodies are composed of a skeleton of beta-sheets. Most of
the amazing variety of antibodies is realized by differences in
sixhypervariableloopsoftheCDRs.Therefore,theCDRshave
previously been deﬁned through these six loops. The ﬁrst def-
initionofCDRswasasregionsintheKabatsequencevariability
plot(13,14).Theresiduesintheseregionsareidentiﬁedthrough
analignmentbetweenthequerysequenceandaconsensusmotif
for antibodies. Although widely used, the Kabat CDR-
deﬁnitions can be problematic because CDRs that are in
structural loops often have very unusual sequences that are
not captured by regular sequence motifs (15). In fact, any
method based only on sequence information is prone to mis-
aligningandthereforemis-assigningloopyCDRs.Chothiaand
co-workers (16) therefore based their CDR identiﬁcation on
structural information. Initially, hypervariable loops were
deﬁned according to a few structures. Later, the numbering
of the residues that was used to locate the CDRs was changed
to account for structures that became available subsequently
(17). Studies also differ in their deﬁnition of secondary struc-
tures, thereby increasing the inconsistency in deﬁning hyper-
variable loops. Additional disadvantages ofboth the Kabatand
Chothia et al. method are described elsewhere (http://www.
bioinf.org.uk/abs/).
Here, we address these problems through a comprehensive
study of all known antigen–antibody complexes in the PDB.
Analyzing the structures, we identiﬁed the consensus residues
on the antibodies and thereby identiﬁed the CDRs on all
known protein–antibody complexes (details below). This
initial set of CDRs facilitated the automatic generation of a
database with all known antigenic residues in the PDB; we
also included the sequence environment and a detailed
description of the CDR with which they interact. Several data-
bases of antibody–antigen complex structures are available
(15,18,19). Some of these databases focus on the structural
aspects of the interaction (19,20). There are also databases
that compile B-cell epitopes without their corresponding
antibodies (12,21). However, none of these databases expli-
citly locates the CDRs or identiﬁes the antigenic residues
semi-automatically. In this sense, our resource is more
comprehensive and easily adjustable to growing data, as
more 3D structures of antigen–antibody complexes become
available. Thus, the databases mentioned above, particularly
the ones that are not structure based, are complementary to
Epitome.
DATABASE
Extraction of 3D structures and identification of CDRs
InordertoidentifyallstructuresinthePDBthatcontainatleast
one antibody–antigen complex, we searched with BLAST (22)
for a consensus sequence of an antibody against the PDB. The
rationale for using BLAST rather than PSI-BLAST was to
avoid capturing molecules such as T-cell receptors which,
despite their similarity to antibodies, participate in cell-
mediated immune response, and therefore represent a different
type of antigenic interaction. We then added PDB structures
that contain an immunoglobulin fold from the Structural
Classiﬁcation of Proteins database (SCOP) (23) and PDB ent-
ries that are identiﬁed as antibody–antigen complexes through
keywords (e.g. ‘antibody’ and ‘antigen’). We discarded all
complexes with T-cell receptors or MHC molecules, since
these are formed during cell-mediated immune response.
We labeled residues as interacting if any of their respective
atoms were within a sphere of <6s (24). This resulted in our
ﬁnallist ofinteractions betweenantibodiesandantigens.Thus,
we deﬁne antibody–antigen interaction as spatial proximity
between a residue within the CDRs and a residue on the sur-
face of the antigenic protein.
We located the CDRs in the known protein–antibody com-
plexes through the following knowledge-based approach. We
began by creating multiple structure alignments of antibody
structures using SKA (25,26). Since the light and heavy chains
have different CDRs, two different multiple structure align-
ments were performed corresponding to each type of antibody
chain. Additionally, due to the fact that our database included
several redundant sequences, we ran the structural alignment
program on a sequence-unique subset of all protein–antibody
complexes. As antibody sequences are highly similar to each
other, the criteria for the redundancy of the complex set was
determined by the antigen sequences; sequence redundancy
wasreducedatHSSP-valuesof0(correspondingto<33%pair-
wise sequence identity for long alignments) (27–30). Then, we
identiﬁedstructurallyalignedpositionsthatinteractwithapro-
tein in more than 10% of the complexes of the alignment. We
deﬁnedthebordersoftheCDRsthroughthosehighlypopulated
positions. Given the CDRs in the aligned antibodies, we trans-
ferredtheirlocationtotheantibodychainsofthecorresponding
sequence–structurefamilythattheyrepresentbystructuralpair-
wise alignments using Combinatorial Extension (CE) (31)
(Figure 1). Finally, we deﬁned all the residues on the protein
surface that are in contact with the residues on the antibody
CDRs as antigenic residues.
Content statistics
Epitome currently contains 142 antigens from protein–
antibody complex structures with a current total of 10180
antigenic interactions. A total of 63 of the complexes consist
of antigens that are sequence-unique, i.e. 63 are such that no
other antigen in the database has a level of sequence similarity
Figure 1. Antigenic residues according to Epitome. Complex structure of
quail lysozyme (in blue) and the light chain of an antibody (in green), as taken
fromPDBID1bql(33).TheresiduesthataredefinedtobeinCDR1ofthelight
chain according to Kabat definition (13) are colored in black. Residues in red
are all the residues that are involved in the interaction according to Epitome.
Note that not all of the residues on the antibody surface that are located on
‘Kabat’CDRareinvolvedintheantigenicreaction.Additionally,although1bql
antibody chains did not participate in the multiple structure alignment, i.e. the
information about the location of the CDR was transferred from a homologous
structure, the interaction was correctly identified.
D778 Nucleic Acids Research, 2006, Vol. 34, Database issueto any other of the 63 that would enable coarse-grained homo-
logy modeling.
Input and fields
Epitome users can search for epitopes either by querying the
database or by entering a sequence and ‘BLASTing’ for sim-
ilar sequences that are stored in the database. The ﬁelds that
can be queried include one or more of the following: PDB
identiﬁer (four-letter code used by the PDB, e.g. 1pdb); Anti-
gen chain ID (PDB identiﬁer for the chain of the antigen, e.g.
1pdb_C),antigen residue type (one lettercode foramino acids,
e.g. Y corresponds to Tyrosine), antigen residue secondary
structure state as deﬁned by DSSP (32) (1 letter code; GHI
corresponds to helical structures, EB to strands and TSL to
other), antigen residue solvent accessibility (the input is the
accessible surface in A ˚ 2 as deﬁned by DSSP (32) and the
search is on all residues with accessibility values that are
bigger or equal to the input value), antigen residue position
(the residue number as annotated in the PDB ﬁle), heavy/light
chain (the interaction involves residues that are located either
on the light or the heavy or both chains of the antibody),
antibody chain identiﬁer (similar to the antigen chain identi-
ﬁer), antibody residue type (one letter code for amino acids,
e.g. C corresponds to Cysteine), antibody residue position in
the PDB (the position of the antibody residue that is involved
in the interaction as annotated by the PDB) and CDR number
(possible values: 1, 2, 3).
Output
Results for database queries are presented as a table that lists
all features of the result sets (Figure 2). The antigen results
include the residues in the environment of the antigen (high-
lighted in red). If a user performs a BLAST sequence search
against the Epitome database to ﬁnd PDB structures contain-
ing antigens with similar sequences, the output will be all
complex structures consisting of proteins with high degree
of similarity to the input sequence, the corresponding E-
value and BLAST score of the pairwise sequence alignments.
Additionally, each PSI-BLAST hit contains a link that can
trigger another database query.
Updates
Since most Epitome entries were identiﬁed using the SCOP
database, Epitome updates will follow updates of SCOP,
i.e. Epitome will be updated twice a year as soon as SCOP
updates its parseable ﬁles. Additionally, all the other programs
used to create the database are installed locally and can be
run automatically.
Figure 2. Screenshotofadatabaseentry.Eachlineofthetablerepresentsdifferentantigenicinteraction,i.e.interactionofaproteinsurfaceresiduewithanantibody
surfaceresiduethatislocatedononeoftheantibody’s6CDRs.Notethatthesearchcouldbeperformedusinganyofthetablefieldsandthatthereisadditionallinkto
visualize the interaction using Jmol (http://jmol.sourceforge.net/).
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